JEMPERLI
Google image searchProduct monograph
Active ingredient
dostarlimab, 50 MG/ML
DIN: 02523434
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE USE VIAL
Schedule: Prescription / Schedule D
Company: GLAXOSMITHKLINE INC
Date: 22-FEB-2022
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
- L01FF — PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors (ATC, ATC/DDD)
- L01FF07 — DOSTARLIMAB (ATC/DDD)
External Links for Jemperli
Search on Google
Glaxosmithkline Inc
Go to GlaxoSmithKline website to see drug product details. Sometimes you can find jemperli photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.